- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2024
- 80 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2022
- 86 Pages
Global
From €3200EUR$3,592USD£2,775GBP
- Report
- July 2024
- 86 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- February 2022
- 86 Pages
Global
From €3200EUR$3,592USD£2,775GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- January 2025
- 132 Pages
Global
From €907EUR$950USD£760GBP

BioMEMS (Biological Micro-Electro-Mechanical Systems) are medical devices that combine biological components with micro-electro-mechanical systems (MEMS) technology. These devices are used in a variety of medical applications, such as drug delivery, diagnostics, and tissue engineering. BioMEMS are designed to be small, low-cost, and easy to use, making them ideal for use in medical settings.
BioMEMS are becoming increasingly popular in the medical device market due to their ability to provide precise and accurate measurements. They are also being used to develop new treatments and therapies, as well as to monitor patient health. Additionally, BioMEMS are being used to improve the accuracy and efficiency of medical procedures.
Some of the companies in the BioMEMS market include Abbott, Medtronic, Johnson & Johnson, Siemens, and Philips. These companies are developing a range of BioMEMS products, from drug delivery systems to diagnostic tools. Additionally, many universities and research institutions are also researching and developing BioMEMS technology. Show Less Read more